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The primary structure of a teleost prepro-urotensin II may be deduced from the nucleotide sequence of cloned DNA complementary to carp prepro- 
urotensin II mRNA but the pathway of post-translational processing of the precursor is unknown. In this study, we have isolated four peptides 
from an extract of flounder urophysis that are derived from prepro-urotensin II by proteolytic cleavage. The amino acid sequences ofthe peptides 
demonstrate that flounder prepro-urotensin II is cleaved at two monobasic processing sites (single arginine residues) to generate peptides with limit- 
ed homology to carp prepro-urotensin 11-(22-41)-, -(42-87)- and -(88-110)-peptides. Cleavage at a tribasic residue processing site generates a uro- 
tensin II with the primary structure: Ala-Gly-Thr-Thr-Glu-Cys-Phe-Trp-Lys-Tyr-Cys-Val. Urotensin I1-(4-12)-peptide represented a minor compo- 
nent in the extract. 
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1. INTRODUCTION 
The caudal  por t ion  of  the spinal cord of  jawed fishes 
contains a neurosecretory organ, the urophysis.  Ex- 
tracts o f  teleost urophyses contain factors with hypo- 
tensive, smooth muscle st imulating, osmoregulatory,  
and steroidogenic activities (reviewed in [1]). These ac- 
tivities may be ascribed, at least in part ,  to the presence 
o f  two peptides in the urophysis:  urotensin I and 
urotensin I I .  Urotensin II has been isolated in single 
molecular  form f rom the goby,  Gillichthys mirabilis [2] 
and in mult ip le molecular  forms f rom the white sucker, 
Catostomus commersoni [3] and carp, Cyprinus carpio 
[4]. The peptides comprise 12 amino acid residues and 
conta in the cyclic sequence: -Cys6-Phe7-TrpS-Lys 9- 
Tyr l° -Cys 11- that has been conserved between the 
species. This region is structural ly similar to the func- 
t ional ly  important  central region of  somatostat in-14: 
-Phe7-Trpa-Lys9-Thr 1°- and urotensin I I  and somato-  
stat in share some common biological  propert ies [3]. 
The complete pr imary  structures of  two biosynthetic 
precursors o f  urotensin I I  (prepro-urotensin II) may be 
deduced f rom the nucleotide sequence o f  cloned DNAs  
complementary  to mRNAs  prepared f rom the caudal  
spinal cord region o f  the carp [5]. The precursors,  
prepro-urotens in  II-ce and prepro-urotens in I I -7, are 
highly homologous and comprise 125 amino acids. 
A l though the pathways of  post- t ranslat ion processing 
o f  fish preprosomatostat ins  have been studied in detai l  
[6,7], the sites o f  post- t ranslat ional  proteolyt ic  leavage 
in prepro-urotens in I I  are unknown.  This study 
describes the isolat ion of  several peptides derived f rom 
prepro-urotens in- I I  f rom an extract of  the urophysis o f  
the f lounder,  Platichytes flesus. Determinat ion of  the 
pr imary  structures of  these peptides has enabled the 
elucidat ion of  the pathway o f  post- t ranslat ional  proc- 
essing of  the precursor.  
2. MATERIALS  AND METHODS 
2.1. Tissue xtraction 
Urophyses from 31 adult flounder were removed following tissue 
exposure by drilling away the overlying vertebral bone and im- 
mediately frozen on solid CO2. The tissue (35 mg wet weight) was 
boiled in 0.25% (v/v) acetic acid (7.8 ml) for 3 min [8] and the mixture 
freeze-dried. The dried material was redissolved in 0.1070 trifluoro- 
acetic acid/water and centrifuged (10 000 x g, 15 min). 
2.2. Purification of the peptides 
The supernatant from the extract was injected onto a semi- 
preparative (250x 10 mm) Vydac 218TP510 column (Separations 
Group) equilibrated with 0.1070 trifluoroacetic a id/water at a flow 
rate of 2 ml/min. The concentration f acetonitrile in the eluting sol- 
vent was raised to 480/0 (v/v) over 90 rain using a linear gradient. Ab- 
sorbance was monitored at 214 nm and 280 nm and peaks were col- 
lected manually without using a fraction collector. The peaks 
designated 1-6 in Fig. 1 were rechromatographed on an analytical 
(250x4.6) Vydac 214TP54 column equilibrated with acetonitrile/ 
water/trifluoroacetic acid (21.0:78.9:0.1) at a flow rate of 1.5 
ml/min. The concentration f acetonitrile in the eluting solvent was 
raised to 48070 (v/v) over 60 rain using a linear gradient. 
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2.3. Characterization f the peptides 
The primary structures of the peptides were determined by 
automated Edman degradation using an Applied Biosystems model 
47 IA sequenator modified for on-line detection of phenylthiohydan- 
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Fig. 1. Reversed-phase HPLC on a semi-preparative Vydac C-18 column of an extract of flounder urophyses. The peaks designated 1-6 were 
selected for further purification. The arrow shows the retention time of synthetic goby urotensin II and ( - -  - )  the concentration f acetonitrile 
in the eluting solvent. 
toin (PTH) amino acids under gradient elution conditions. The 
manufacturer's standard operating procedures were used and the 
detection limit for PTH amino acids was 0.5 pmol. Californium-252 
plasma desorption time-of-flight mass spectrometry was carried out 
using a BIO-ION Nordic BIN-10K instrument as described [9]. The 
accuracy of the mass determinations was approximately :i: 0.1 °70. 
3. RESULTS 
3.1. Purification of peptides derived from pro- 
urotensin H 
The elution profile on a semi-preparative Vydac C-18 
column of the extract of flounder urophyses i  shown in 
Fig. 1. The chromatogram contained six partially 
resolved peaks (designated 1-6) whose retention times 
were similar to that of synthetic goby urotensin II. The 
peptides in these peaks were purified to apparent 
homogeneity by rechromatography on a Vydac C-4 
column. 
3.2. Structural characterization 
In view of the small amounts of pure material 
available, approximately 90°70 of the total quantity of 
peptides was subjected to automated Edman degrada- 
tion. The results of the structural analysis are sum- 
marized in Table I. Peptide 1 represented flounder 
urotensin II. Confirmation of the proposed structure, 
including the presence of a cystine bridge, was provided 
by mass spectrometry. A strong molecular ion (MH +) 
was identified at 1406.7+ 1.4 amu compared with a 
calculated MH + of 1406 for the proposed sequence. Ed- 
man degradation of peptide 3 indicated the probable 
amino acid sequence: Thr-Glu-X-Phe-Trp-Lys-Tyr-X- 
Table 1 
A comparison of the amino acid sequences ofpeptides derived from flounder pro- 
urotensin II with the predicted sequences from the corresponding region of carp 
pro-urotensin II-o~ 
Carp 
Flounder 
Carp 
Flounder 
Carp 
Flounder 
10 20 
HPVTDTADMTYSGPDSVEEA 
- - , - , , - , - , - , - - , - , - - , "  (55%) 
30 40 
GGVSPDDFAVSDLNDLLQRAA 
-VG-L- -LSL-EQ-YPP- -G-  
50 60 
VVGYSPLLSRENIKVPGQIPKEALR*  
GLR-AT- .  . . . . . . . . . . . . . . . .  (39%) 
70 80 90  
ELLLEKPYRL IPPSGLWGSRRQFR*K*R*  
-V  . . . .  QSL -N-F -RVF- I -K - -  (52%)  
IO0 
Carp GGGADCFWKYCV 
Flounder A-TTE . . . . . . .  (67%) 
(-) denotes residue identity and the values in parentheses show o70 homologies be- 
tween corresponding regions of the carp and flounder precursors. The R-20, R-66 
and R-90 K-91 R-92 residues, denoted by asterisks, represent putative sites of post- 
translational processing of pro-urotensin II 
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Val. corresponding to urotensin II-(4-12)-peptide. 
Mass spectrometry confirmed the proposed sequence 
and indicated the presence of a cystine bridge in the 
molecule. A strong molecular ion (MH ÷) was detected 
at 1175.7+ 1.2 compared with a calculated MH ÷ of 
1176. A second strong signal was observed at MH ÷ 
1187.4+1.2 suggesting that peptide 3 may not have 
been pure. 
Peptide 5 was shown to be a 20-amino-acid-residue 
peptide terminating in an arginyl residue and peptide 6
was a 23-amino-acid residue peptide. Comparison with 
the predicted amino acid sequence of carp prepro- 
urotensin II [5] demonstrates that peptide 5 represents 
flounder pro-urotensin II-(1-20)-peptide and peptide 6 
represents flounder pro-urotensin II-(67-89)-peptide. It 
was not possible to obtain the complete amino acid se- 
quence of peptide 4. PTH-derivatives were unam- 
biguously identified uring cycles (1-26), a threonine 
residue was detected in trace amount only at cycle 27 
and a leucine residue was detected at cycle 28. Com- 
parison with the predicted structure of carp prepro- 
urotensin II [5] demonstrates that the partial sequence 
of peptide 4 may represent he NH2-terminus of 
flounder pro-urotensin II-(21-66)-peptide. 
4. DISCUSSION 
A comparison of the amino acid sequences of four 
peptides derived from flounder prepro-urotensin II 
with the sequences of peptides from the corresponding 
region of carp prepro-urotensin II (predicted from the 
nucleotide sequence of a cDNA) shows that the primary 
structure of the precursor has not been well conserved 
between the species. Strong evolutionary pressure ap- 
pears to have acted to conserve only the sequence at 
COOH-terminus of the molecule, i.e. the cyclic region 
of urotensin II. The degree of homology of the three 
peptides in the NH2-region of the precursor is only 
39-55% (Table I). The data suggest, but do not prove, 
that the NH2-flanking peptides in the pro-urotensin II 
molecule do not have a regulatory role. Similarly, the 
demonstration that the NH2-region of the precursor is 
cleaved into several fragments shows that the prepro- 
urotensin II gene does not direct the synthesis of a 
urophysin (urotensin-binding protein) analogous to the 
neurophysins [10]. 
It has been proposed that conformation features in 
the prohormone r gulate the specificity of cleavage by 
the processing enzymes. In the case of processing at the 
site of multiple basic residues, the cleavage sites are 
often located inside, or immediately adjacent to, 
regions with a high probability of ~'-turn formation [11] 
or alternatively are associated with f/ loops [12]. 
Schwartz has identified proximity to proline residues as 
an important conformational feature regulating 
cleavage at single arginine residues in some precursor 
peptides [13] whereas Benoit et al. have claimed that the 
monobasic site must be in a domain containing an addi- 
tional basic residue together with leucine and/or 
alanine residues [14]. Isolation of flounder pro- 
urotensin II-(1-20)-peptide, which contains a COOH- 
terminal arginine residue, identifies the site of cleavage 
of the signal peptide and provides good evidence that 
the precursor is cleaved a monobasic processing site. 
The Arg-20 residue, however, is not located in the 
neighbourhood f a proline residue or in a domain con- 
taining a second basic residue. Evidence for the occur- 
rence of a second monobasic cleavage in flounder pro- 
urotensin II is indirect. Carp prepro-urotensin II con- 
tains a single arginine residue at position 87 which cor- 
responds to position 66 in flounder pro-urotensin II. In 
the carp preprohormone, Arg-87 is located in a region 
containing an additional basic residue (lysine) and one 
alanine and four leucine residues. Although it was not 
possible with the limited amount of pure material 
available to obtain the amino acid sequence at the 
COOH-terminus of peptide 4 (the putative pro- 
urotensin II-(21-66)-peptide), isolation and full struc- 
tural characterization of pro-urotensin 11-(67-89)- 
peptide suggests that cleavage may have occurred at 
Arg-66 in the flounder precursor. This study has 
demonstrated that the Arg-86 Lys-87 potential dibasic 
residue processing site in flounder pro-urotensin II (cor- 
responding to Arg-107 Arg-108 in the carp preprohor- 
mone) is not recognized by the processing enzyme(s). 
This site is not located in or immediately adjacent to a 
E-turn. 
The pathway of post-translational processing of 
flounder pro-urotensin II may be compared with the 
pathway of processing of flounder prosomatostatin II 
[7]. In the pancreatic slets, prosomatostatin II is cleav- 
ed at a dibasic residue processing site in the central 
region of the molecule and the resulting fragments are 
cleaved at monobasic (single arginine) sites. The 
primary structures of the prosomatostatin fragments 
demonstrated that the COOH-terminal rginine residue 
was removed following (or concomitant with) cleavage 
by the monobasic processing enzyme. Determination f 
the primary structure of flounder pro-urotensin II- 
(1-20)-peptide has shown that the COOH-terminal 
arginine residue has not been removed from the frag- 
ment. This difference in processing pathways may 
reflect a difference in concentration f carboxpeptidase 
E in the urophysis and pancreatic slets. 
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